Follow
Daniel Gaudet
Daniel Gaudet
ecogene21 Biocluster and dept of Medicine Université de Montréal
Verified email at umontreal.ca
Title
Cited by
Cited by
Year
The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
D Altshuler, JN Hirschhorn, M Klannemark, CM Lindgren, MC Vohl, ...
Nature genetics 26 (1), 76-80, 2000
23672000
Simvastatin with or without ezetimibe in familial hypercholesterolemia
JJP Kastelein, F Akdim, ESG Stroes, AH Zwinderman, ML Bots, ...
New England Journal of Medicine 358 (14), 1431-1443, 2008
17022008
Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?
I Lemieux, A Pascot, C Couillard, B Lamarche, A Tchernof, N Alméras, ...
Circulation 102 (2), 179-184, 2000
14412000
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
AF Hernandez, JB Green, S Janmohamed, RB D'Agostino, CB Granger, ...
The Lancet 392 (10157), 1519-1529, 2018
13552018
Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised …
FJ Raal, RD Santos, DJ Blom, AD Marais, MJ Charng, WC Cromwell, ...
The Lancet 375 (9719), 998-1006, 2010
10382010
Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease
JD Rioux, MJ Daly, MS Silverberg, K Lindblad, H Steinhart, Z Cohen, ...
Nature genetics 29 (2), 223-228, 2001
9752001
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial
FJ Raal, EA Stein, R Dufour, T Turner, F Civeira, L Burgess, G Langslet, ...
The Lancet 385 (9965), 331-340, 2015
8752015
Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study
M Cuchel, EA Meagher, H du Toit Theron, DJ Blom, AD Marais, ...
The Lancet 381 (9860), 40-46, 2013
8102013
Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on …
EA Stein, D Gipe, J Bergeron, D Gaudet, R Weiss, R Dufour, R Wu, ...
The Lancet 380 (9836), 29-36, 2012
6812012
Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia
C Gagné, D Gaudet, E Bruckert
Circulation 105 (21), 2469-2475, 2002
6162002
Common variants in the NLRP3 region contribute to Crohn's disease susceptibility
AC Villani, M Lemire, G Fortin, E Louis, MS Silverberg, C Collette, N Baba, ...
Nature genetics 41 (1), 71-76, 2009
5812009
Antisense inhibition of apolipoprotein C-III in patients with hypertriglyceridemia
D Gaudet, VJ Alexander, BF Baker, D Brisson, K Tremblay, W Singleton, ...
New England Journal of Medicine 373 (5), 438-447, 2015
5522015
Evinacumab for homozygous familial hypercholesterolemia
FJ Raal, RS Rosenson, LF Reeskamp, GK Hovingh, JJP Kastelein, ...
New England Journal of Medicine 383 (8), 711-720, 2020
5252020
Targeting APOC3 in the familial chylomicronemia syndrome
D Gaudet, D Brisson, K Tremblay, VJ Alexander, W Singleton, SG Hughes, ...
New England Journal of Medicine 371 (23), 2200-2206, 2014
4822014
Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial
D Gaudet, J Méthot, S Déry, D Brisson, C Essiembre, G Tremblay, ...
Gene therapy 20 (4), 361-369, 2013
4612013
Volanesorsen and triglyceride levels in familial chylomicronemia syndrome
JL Witztum, D Gaudet, SD Freedman, VJ Alexander, A Digenio, ...
New England Journal of Medicine 381 (6), 531-542, 2019
4332019
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus …
HN Ginsberg, CJ Packard, MJ Chapman, J Borén, CA Aguilar-Salinas, ...
European heart journal 42 (47), 4791-4806, 2021
4012021
Efficacy and safety of bempedoic acid in patients with hypercholesterolemia and statin intolerance
U Laufs, M Banach, GBJ Mancini, D Gaudet, LAT Bloedon, LR Sterling, ...
Journal of the American Heart Association 8 (7), e011662, 2019
3842019
Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene region
JC Florez, N Burtt, PIW De Bakker, P Almgren, T Tuomi, J Holmkvist, ...
Diabetes 53 (5), 1360-1368, 2004
3772004
Apolipoprotein B synthesis inhibition with mipomersen in heterozygous familial hypercholesterolemia: results of a randomized, double-blind, placebo-controlled trial to assess …
EA Stein, R Dufour, C Gagne, D Gaudet, C East, JM Donovan, W Chin, ...
Circulation 126 (19), 2283-2292, 2012
3442012
The system can't perform the operation now. Try again later.
Articles 1–20